Evidence-Based Oncology > October 2015

Evidence-Based Oncology - October 2015

October 06, 2015 – Lisa Diller, MD
Suggestions on how to approach a childhood cancer survivor in your practice, several useful resources, and information on what referrals and tests may be indicated.
October 06, 2015 – Bree Hemingway, MPH; Aditi Narayan, MSW; Sarah Avery, PhD
A discussion on the challenges of implementing standards for addressing fertility risks associated with cancer and its treatment and describes an interactive training for healthcare providers to help them overcome challenges to implementation.
October 06, 2015 – Clarke P. Anderson, MD
End-of-life care for adolescents and young adults requires an approach that addresses the unique developmental and spiritual issues seen in that population.
October 07, 2015 – Joseph Alvarnas, MD
A missed opportunity in cancer care, according to Joseph Alvarnas, MD, is the use of age-adapted treatment strategies for adolescent and young-adult patients (AYA).
October 08, 2015 – Woodrow Roseland
My role as a patient was simple-accept the suffering I had to endure. But it becomes hard to find the line between when to suffer and when to question.
October 08, 2015 – Joseph Rosenthal, MD
Adolescent and young adults (AYA) constitute a distinct population amongst patients with cancer. Historically, AYA patients with ALL treated along pediatric-inspired protocols had better outcomes compared to those treated on standard "adult type" regimens.
October 08, 2015 – Laurel Barosh, MPH; Terry Church, MA, MS; Deborah Morgan, MSN, RN, OCN; Megan Bianchetti, MSW; James Hu, MD, FACP; Debu Tripathy, MD; Stuart E. Siegel, MD
Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.
October 12, 2015 – Robert Chapman, MD
Changes in the healthcare marketplace are steadily pushing changes for physicians and specialty practices of all kinds. Blaming the 340B drug discount program is both misleading and unproductive.
October 12, 2015 – Surabhi Dangi-Garimella, PhD
Evidence-Based Oncology spoke with Rajen Mody, MBBS, from the University of Michigan Health System, about his experiences treating young cancer patients, the survivorship program offered by the University of Michigan, and next generation sequencing.
October 12, 2015 – Surabhi Dangi-Garimella, PhD
Adolescent and young adult cancer patients face multiple barriers to ensuring adequate care: from unsure providers to financial constraints. Improved care coordination and recognition of the needs of this population can lead to much improved outcomes.
October 14, 2015 – Surabhi Dangi-Garimella, PhD; Mary Caffrey
An update on recent progress in oncology managed care.
October 14, 2015 – Surabhi Dangi-Garimella, PhD
Evaluation of Prosigna's risk of relapse score as a predictor of response to multiagent neoadjuvant chemotherapy in HR+/HER2 breast cancer patients.
October 14, 2015 – Surabhi Dangi-Garimella, PhD
Updates on FDA approvals and extended indications for oncology drugs.
October 14, 2015 – Samantha Watson, MBA; and Michelle S. Landwehr, MPH
The financial aftereffects of cancer have a tremendous impact on young adults as they move forward with their lives after treatment.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.